BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8585114)

  • 1. Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay.
    Gonschior AK; Christians U; Winkler M; Schiebel HM; Linck A; Sewing KF
    Ther Drug Monit; 1995 Oct; 17(5):504-10. PubMed ID: 8585114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry.
    Zhang Q; Simpson J; Aboleneen HI
    Ther Drug Monit; 1997 Aug; 19(4):470-6. PubMed ID: 9263391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
    Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
    Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry.
    Keevil BG; McCann SJ; Cooper DP; Morris MR
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):487-92. PubMed ID: 12227855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay.
    Alak AM; Moy S; Cook M; Lizak P; Niggebiugge A; Menard S; Chilton A
    J Pharm Biomed Anal; 1997 Sep; 16(1):7-13. PubMed ID: 9447546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL; Lynch SV; Shaw LM; Pond SM
    Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
    Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
    Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in monitoring tacrolimus (FK 506).
    Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
    Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients.
    Salm P; Rutherford DM; Taylor PJ; Black MJ; Pillans PI
    Clin Biochem; 2000 Oct; 33(7):557-62. PubMed ID: 11124341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedure for determination of immunosuppressive drugs in whole blood with liquid chromatography-isotope dilution mass spectrometry.
    Molnár PM; Dux L; Reinauer H; Kress M; Akerboom T; Szederkényi E; Kaiser P
    Clin Lab; 2011; 57(11-12):983-92. PubMed ID: 22239031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
    Cogill JL; Taylor PJ; Westley IS; Morris RG; Lynch SV; Johnson AG
    Clin Chem; 1998 Sep; 44(9):1942-6. PubMed ID: 9732981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).
    Gonschior AK; Christians U; Braun F; Winkler M; Linck A; Baumann J; Sewing KF
    Br J Clin Pharmacol; 1994 Dec; 38(6):567-71. PubMed ID: 7534100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.
    Hinchliffe E; Adaway JE; Keevil BG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():102-7. PubMed ID: 21680259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract]   [Full Text] [Related]  

  • 17. A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood.
    Salm P; Taylor PJ; Rooney F
    Ther Drug Monit; 2008 Jun; 30(3):292-300. PubMed ID: 18520600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients.
    Gonschior AK; Christians U; Winkler M; Linck A; Baumann J; Sewing KF
    Clin Chem; 1996 Sep; 42(9):1426-32. PubMed ID: 8787699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
    Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
    Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.